nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—vein—atherosclerosis	0.113	0.466	CbGeAlD
Alendronate—Regurgitation—Lovastatin—atherosclerosis	0.0208	0.0425	CcSEcCtD
Alendronate—Regurgitation—Simvastatin—atherosclerosis	0.0195	0.0397	CcSEcCtD
Alendronate—PTPRE—cardiovascular system—atherosclerosis	0.016	0.066	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—SOCS3—atherosclerosis	0.0152	0.0594	CbGpPWpGaD
Alendronate—PTPRS—connective tissue—atherosclerosis	0.015	0.0618	CbGeAlD
Alendronate—PTPRE—adipose tissue—atherosclerosis	0.0141	0.0582	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—BGN—atherosclerosis	0.0137	0.0535	CbGpPWpGaD
Alendronate—PTPN4—adipose tissue—atherosclerosis	0.0134	0.0554	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—CRP—atherosclerosis	0.0116	0.0453	CbGpPWpGaD
Alendronate—PTPRS—adipose tissue—atherosclerosis	0.0115	0.0475	CbGeAlD
Alendronate—FDPS—Cholesterol Biosynthesis—HMGCR—atherosclerosis	0.0108	0.0423	CbGpPWpGaD
Alendronate—PTPRE—liver—atherosclerosis	0.00991	0.0408	CbGeAlD
Alendronate—PTPN4—liver—atherosclerosis	0.00943	0.0388	CbGeAlD
Alendronate—Transaminases increased—Lovastatin—atherosclerosis	0.00836	0.017	CcSEcCtD
Alendronate—Transaminases increased—Ezetimibe—atherosclerosis	0.0082	0.0167	CcSEcCtD
Alendronate—PTPRS—liver—atherosclerosis	0.00808	0.0333	CbGeAlD
Alendronate—FDPS—Cholesterol biosynthesis—HMGCR—atherosclerosis	0.00795	0.0311	CbGpPWpGaD
Alendronate—Transaminases increased—Simvastatin—atherosclerosis	0.00782	0.0159	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NCF1—atherosclerosis	0.00743	0.0291	CbGpPWpGaD
Alendronate—Transaminases increased—Pravastatin—atherosclerosis	0.00707	0.0144	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—CYBA—atherosclerosis	0.00699	0.0274	CbGpPWpGaD
Alendronate—ATP6V1A—adipose tissue—atherosclerosis	0.00665	0.0274	CbGeAlD
Alendronate—FDPS—connective tissue—atherosclerosis	0.00652	0.0269	CbGeAlD
Alendronate—Drug interaction—Rosuvastatin—atherosclerosis	0.00647	0.0132	CcSEcCtD
Alendronate—Histamine Phosphate—HRH1—atherosclerosis	0.00637	0.56	CrCbGaD
Alendronate—Heartburn—Niacin—atherosclerosis	0.00635	0.0129	CcSEcCtD
Alendronate—Heartburn—Pravastatin—atherosclerosis	0.00625	0.0127	CcSEcCtD
Alendronate—PTPRE—IL6-mediated signaling events—STAT3—atherosclerosis	0.00605	0.0237	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ELN—atherosclerosis	0.00587	0.023	CbGpPWpGaD
Alendronate—FDPS—cardiovascular system—atherosclerosis	0.00568	0.0234	CbGeAlD
Alendronate—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00552	0.0113	CcSEcCtD
Alendronate—Drug interaction—Ezetimibe—atherosclerosis	0.00538	0.011	CcSEcCtD
Alendronate—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00515	0.0105	CcSEcCtD
Alendronate—Drug interaction—Simvastatin—atherosclerosis	0.00513	0.0105	CcSEcCtD
Alendronate—FDPS—adipose tissue—atherosclerosis	0.00501	0.0206	CbGeAlD
Alendronate—FDPS—Activation of gene expression by SREBF (SREBP)—HMGCR—atherosclerosis	0.00493	0.0193	CbGpPWpGaD
Alendronate—ATP6V1A—liver—atherosclerosis	0.00466	0.0192	CbGeAlD
Alendronate—Drug interaction—Pravastatin—atherosclerosis	0.00464	0.00945	CcSEcCtD
Alendronate—PTPRS—ECM proteoglycans—SERPINE1—atherosclerosis	0.0045	0.0176	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—HMOX1—atherosclerosis	0.00445	0.0174	CbGpPWpGaD
Alendronate—ATP6V1A—Insulin receptor recycling—INS—atherosclerosis	0.00436	0.0171	CbGpPWpGaD
Alendronate—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00435	0.00887	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP8—atherosclerosis	0.00433	0.017	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—atherosclerosis	0.00423	0.0166	CbGpPWpGaD
Alendronate—Photosensitivity—Lovastatin—atherosclerosis	0.0042	0.00857	CcSEcCtD
Alendronate—Photosensitivity—Ezetimibe—atherosclerosis	0.00412	0.00841	CcSEcCtD
Alendronate—Oesophagitis—Niacin—atherosclerosis	0.00399	0.00813	CcSEcCtD
Alendronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCR—atherosclerosis	0.00393	0.0154	CbGpPWpGaD
Alendronate—Photosensitivity—Simvastatin—atherosclerosis	0.00393	0.00802	CcSEcCtD
Alendronate—PTPRE—IL6-mediated signaling events—AKT1—atherosclerosis	0.0039	0.0153	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BGN—atherosclerosis	0.0039	0.0153	CbGpPWpGaD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—atherosclerosis	0.00383	0.015	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—LDLR—atherosclerosis	0.00361	0.0141	CbGpPWpGaD
Alendronate—Photosensitivity—Pravastatin—atherosclerosis	0.00355	0.00725	CcSEcCtD
Alendronate—FDPS—liver—atherosclerosis	0.00351	0.0145	CbGeAlD
Alendronate—FDPS—SREBP signalling—SCARB1—atherosclerosis	0.00337	0.0132	CbGpPWpGaD
Alendronate—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00332	0.00678	CcSEcCtD
Alendronate—Cramp muscle—Lovastatin—atherosclerosis	0.00332	0.00678	CcSEcCtD
Alendronate—Cramp muscle—Ezetimibe—atherosclerosis	0.00326	0.00665	CcSEcCtD
Alendronate—Gastritis—Ezetimibe—atherosclerosis	0.0032	0.00653	CcSEcCtD
Alendronate—FDPS—SREBP signalling—HMGCR—atherosclerosis	0.00318	0.0125	CbGpPWpGaD
Alendronate—Cramp muscle—Simvastatin—atherosclerosis	0.00311	0.00634	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00311	0.00634	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—atherosclerosis	0.00308	0.0121	CbGpPWpGaD
Alendronate—Abdominal discomfort—Lovastatin—atherosclerosis	0.00306	0.00623	CcSEcCtD
Alendronate—Gastritis—Simvastatin—atherosclerosis	0.00306	0.00623	CcSEcCtD
Alendronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—atherosclerosis	0.00304	0.0119	CbGpPWpGaD
Alendronate—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00291	0.00594	CcSEcCtD
Alendronate—Dry skin—Niacin—atherosclerosis	0.00291	0.00592	CcSEcCtD
Alendronate—Dry skin—Pravastatin—atherosclerosis	0.00286	0.00583	CcSEcCtD
Alendronate—Abdominal discomfort—Simvastatin—atherosclerosis	0.00286	0.00583	CcSEcCtD
Alendronate—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00286	0.00582	CcSEcCtD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—atherosclerosis	0.00284	0.0111	CbGpPWpGaD
Alendronate—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00282	0.00575	CcSEcCtD
Alendronate—Cramp muscle—Pravastatin—atherosclerosis	0.00281	0.00573	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00281	0.00573	CcSEcCtD
Alendronate—Abdominal distension—Niacin—atherosclerosis	0.00276	0.00562	CcSEcCtD
Alendronate—Dysphagia—Niacin—atherosclerosis	0.00274	0.00559	CcSEcCtD
Alendronate—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00272	0.00555	CcSEcCtD
Alendronate—Abdominal distension—Pravastatin—atherosclerosis	0.00272	0.00554	CcSEcCtD
Alendronate—Risedronate—PTGS2—atherosclerosis	0.00264	0.233	CrCbGaD
Alendronate—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00264	0.00538	CcSEcCtD
Alendronate—Flatulence—Rosuvastatin—atherosclerosis	0.00258	0.00527	CcSEcCtD
Alendronate—Oedema peripheral—Ezetimibe—atherosclerosis	0.00247	0.00503	CcSEcCtD
Alendronate—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00246	0.00502	CcSEcCtD
Alendronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atherosclerosis	0.00243	0.00952	CbGpPWpGaD
Alendronate—Erythema multiforme—Lovastatin—atherosclerosis	0.00241	0.00492	CcSEcCtD
Alendronate—Angioedema—Rosuvastatin—atherosclerosis	0.0024	0.00489	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00238	0.00486	CcSEcCtD
Alendronate—Stomatitis—Niacin—atherosclerosis	0.00238	0.00485	CcSEcCtD
Alendronate—Erythema multiforme—Ezetimibe—atherosclerosis	0.00237	0.00483	CcSEcCtD
Alendronate—FDPS—SREBP signalling—SIRT1—atherosclerosis	0.00237	0.00927	CbGpPWpGaD
Alendronate—Clodronate—PTGS2—atherosclerosis	0.00236	0.207	CrCbGaD
Alendronate—PTPRS—Extracellular matrix organization—PLG—atherosclerosis	0.00231	0.00905	CbGpPWpGaD
Alendronate—Erythema multiforme—Simvastatin—atherosclerosis	0.00226	0.0046	CcSEcCtD
Alendronate—Alopecia—Lovastatin—atherosclerosis	0.00226	0.0046	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—VCAM1—atherosclerosis	0.00226	0.00884	CbGpPWpGaD
Alendronate—Myalgia—Rosuvastatin—atherosclerosis	0.00223	0.00455	CcSEcCtD
Alendronate—FDPS—SREBP signalling—LPL—atherosclerosis	0.00223	0.00873	CbGpPWpGaD
Alendronate—Alopecia—Ezetimibe—atherosclerosis	0.00221	0.00451	CcSEcCtD
Alendronate—Haemoglobin—Niacin—atherosclerosis	0.0022	0.00449	CcSEcCtD
Alendronate—Haemorrhage—Niacin—atherosclerosis	0.00219	0.00447	CcSEcCtD
Alendronate—Flatulence—Lovastatin—atherosclerosis	0.00219	0.00447	CcSEcCtD
Alendronate—Erythema—Ezetimibe—atherosclerosis	0.00218	0.00444	CcSEcCtD
Alendronate—Dysgeusia—Lovastatin—atherosclerosis	0.00218	0.00444	CcSEcCtD
Alendronate—Oedema peripheral—Niacin—atherosclerosis	0.00216	0.0044	CcSEcCtD
Alendronate—Flatulence—Ezetimibe—atherosclerosis	0.00215	0.00438	CcSEcCtD
Alendronate—Muscle spasms—Lovastatin—atherosclerosis	0.00214	0.00436	CcSEcCtD
Alendronate—Infection—Rosuvastatin—atherosclerosis	0.00213	0.00434	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP3—atherosclerosis	0.00211	0.00828	CbGpPWpGaD
Alendronate—Alopecia—Simvastatin—atherosclerosis	0.00211	0.0043	CcSEcCtD
Alendronate—Muscle spasms—Ezetimibe—atherosclerosis	0.0021	0.00427	CcSEcCtD
Alendronate—Erythema—Simvastatin—atherosclerosis	0.00208	0.00424	CcSEcCtD
Alendronate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00206	0.0042	CcSEcCtD
Alendronate—Flatulence—Simvastatin—atherosclerosis	0.00205	0.00418	CcSEcCtD
Alendronate—Erythema multiforme—Pravastatin—atherosclerosis	0.00204	0.00416	CcSEcCtD
Alendronate—Dysgeusia—Simvastatin—atherosclerosis	0.00204	0.00415	CcSEcCtD
Alendronate—Angioedema—Lovastatin—atherosclerosis	0.00203	0.00414	CcSEcCtD
Alendronate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00202	0.00412	CcSEcCtD
Alendronate—Anaemia—Ezetimibe—atherosclerosis	0.00202	0.00411	CcSEcCtD
Alendronate—Malaise—Lovastatin—atherosclerosis	0.002	0.00409	CcSEcCtD
Alendronate—Muscle spasms—Simvastatin—atherosclerosis	0.002	0.00408	CcSEcCtD
Alendronate—Vertigo—Lovastatin—atherosclerosis	0.002	0.00407	CcSEcCtD
Alendronate—Angioedema—Ezetimibe—atherosclerosis	0.00199	0.00406	CcSEcCtD
Alendronate—Malaise—Ezetimibe—atherosclerosis	0.00197	0.00401	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00195	0.00398	CcSEcCtD
Alendronate—Alopecia—Niacin—atherosclerosis	0.00194	0.00395	CcSEcCtD
Alendronate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00193	0.00393	CcSEcCtD
Alendronate—Anaemia—Simvastatin—atherosclerosis	0.00192	0.00392	CcSEcCtD
Alendronate—Erythema—Niacin—atherosclerosis	0.00191	0.00389	CcSEcCtD
Alendronate—Alopecia—Pravastatin—atherosclerosis	0.00191	0.00389	CcSEcCtD
Alendronate—Angioedema—Simvastatin—atherosclerosis	0.0019	0.00387	CcSEcCtD
Alendronate—Myalgia—Lovastatin—atherosclerosis	0.00189	0.00386	CcSEcCtD
Alendronate—Chest pain—Lovastatin—atherosclerosis	0.00189	0.00386	CcSEcCtD
Alendronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.00188	0.00384	CcSEcCtD
Alendronate—Flatulence—Niacin—atherosclerosis	0.00188	0.00383	CcSEcCtD
Alendronate—Malaise—Simvastatin—atherosclerosis	0.00188	0.00382	CcSEcCtD
Alendronate—Discomfort—Lovastatin—atherosclerosis	0.00187	0.00381	CcSEcCtD
Alendronate—Vertigo—Simvastatin—atherosclerosis	0.00187	0.00381	CcSEcCtD
Alendronate—Myalgia—Ezetimibe—atherosclerosis	0.00186	0.00378	CcSEcCtD
Alendronate—Chest pain—Ezetimibe—atherosclerosis	0.00186	0.00378	CcSEcCtD
Alendronate—Flatulence—Pravastatin—atherosclerosis	0.00185	0.00378	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—SPP1—atherosclerosis	0.00185	0.00724	CbGpPWpGaD
Alendronate—Dysgeusia—Pravastatin—atherosclerosis	0.00184	0.00375	CcSEcCtD
Alendronate—Muscle spasms—Niacin—atherosclerosis	0.00184	0.00374	CcSEcCtD
Alendronate—Discomfort—Ezetimibe—atherosclerosis	0.00183	0.00374	CcSEcCtD
Alendronate—Pain—Rosuvastatin—atherosclerosis	0.00183	0.00373	CcSEcCtD
Alendronate—Constipation—Rosuvastatin—atherosclerosis	0.00183	0.00373	CcSEcCtD
Alendronate—Muscle spasms—Pravastatin—atherosclerosis	0.00181	0.00368	CcSEcCtD
Alendronate—Infection—Lovastatin—atherosclerosis	0.0018	0.00367	CcSEcCtD
Alendronate—Chest pain—Simvastatin—atherosclerosis	0.00177	0.00361	CcSEcCtD
Alendronate—Myalgia—Simvastatin—atherosclerosis	0.00177	0.00361	CcSEcCtD
Alendronate—Infection—Ezetimibe—atherosclerosis	0.00177	0.0036	CcSEcCtD
Alendronate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00176	0.0036	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00176	0.00689	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00175	0.00357	CcSEcCtD
Alendronate—Discomfort—Simvastatin—atherosclerosis	0.00175	0.00357	CcSEcCtD
Alendronate—Angioedema—Niacin—atherosclerosis	0.00174	0.00356	CcSEcCtD
Alendronate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00174	0.00356	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00174	0.00682	CbGpPWpGaD
Alendronate—Anaemia—Pravastatin—atherosclerosis	0.00174	0.00354	CcSEcCtD
Alendronate—Angioedema—Pravastatin—atherosclerosis	0.00172	0.0035	CcSEcCtD
Alendronate—Vertigo—Niacin—atherosclerosis	0.00172	0.0035	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—PDGFB—atherosclerosis	0.00171	0.0067	CbGpPWpGaD
Alendronate—Urticaria—Rosuvastatin—atherosclerosis	0.0017	0.00347	CcSEcCtD
Alendronate—Malaise—Pravastatin—atherosclerosis	0.0017	0.00346	CcSEcCtD
Alendronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00169	0.00345	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP1—atherosclerosis	0.00169	0.00662	CbGpPWpGaD
Alendronate—Vertigo—Pravastatin—atherosclerosis	0.00169	0.00344	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00169	0.00661	CbGpPWpGaD
Alendronate—Infection—Simvastatin—atherosclerosis	0.00169	0.00344	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00165	0.00337	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00164	0.00641	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—PPARG—atherosclerosis	0.00163	0.00637	CbGpPWpGaD
Alendronate—Myalgia—Niacin—atherosclerosis	0.00163	0.00331	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00162	0.0033	CcSEcCtD
Alendronate—Chest pain—Pravastatin—atherosclerosis	0.0016	0.00326	CcSEcCtD
Alendronate—Myalgia—Pravastatin—atherosclerosis	0.0016	0.00326	CcSEcCtD
Alendronate—Dyspepsia—Lovastatin—atherosclerosis	0.0016	0.00326	CcSEcCtD
Alendronate—FDPS—SREBP signalling—INS—atherosclerosis	0.00159	0.00625	CbGpPWpGaD
Alendronate—Discomfort—Pravastatin—atherosclerosis	0.00158	0.00322	CcSEcCtD
Alendronate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00158	0.00322	CcSEcCtD
Alendronate—Dyspepsia—Ezetimibe—atherosclerosis	0.00157	0.00319	CcSEcCtD
Alendronate—Constipation—Lovastatin—atherosclerosis	0.00155	0.00316	CcSEcCtD
Alendronate—Pain—Lovastatin—atherosclerosis	0.00155	0.00316	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00155	0.00315	CcSEcCtD
Alendronate—Asthenia—Rosuvastatin—atherosclerosis	0.00154	0.00313	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—ICAM1—atherosclerosis	0.00154	0.00602	CbGpPWpGaD
Alendronate—Infection—Pravastatin—atherosclerosis	0.00152	0.00311	CcSEcCtD
Alendronate—Constipation—Ezetimibe—atherosclerosis	0.00152	0.0031	CcSEcCtD
Alendronate—Pain—Ezetimibe—atherosclerosis	0.00152	0.0031	CcSEcCtD
Alendronate—Pruritus—Rosuvastatin—atherosclerosis	0.00151	0.00309	CcSEcCtD
Alendronate—Feeling abnormal—Lovastatin—atherosclerosis	0.0015	0.00305	CcSEcCtD
Alendronate—Dyspepsia—Simvastatin—atherosclerosis	0.00149	0.00304	CcSEcCtD
Alendronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00148	0.00302	CcSEcCtD
Alendronate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00147	0.00299	CcSEcCtD
Alendronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00146	0.00299	CcSEcCtD
Alendronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00146	0.00297	CcSEcCtD
Alendronate—Constipation—Simvastatin—atherosclerosis	0.00145	0.00296	CcSEcCtD
Alendronate—Pain—Simvastatin—atherosclerosis	0.00145	0.00296	CcSEcCtD
Alendronate—Urticaria—Lovastatin—atherosclerosis	0.00144	0.00294	CcSEcCtD
Alendronate—Abdominal pain—Lovastatin—atherosclerosis	0.00143	0.00292	CcSEcCtD
Alendronate—Body temperature increased—Lovastatin—atherosclerosis	0.00143	0.00292	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00142	0.00289	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00142	0.00556	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00142	0.00556	CbGpPWpGaD
Alendronate—Dizziness—Rosuvastatin—atherosclerosis	0.00142	0.00289	CcSEcCtD
Alendronate—Urticaria—Ezetimibe—atherosclerosis	0.00141	0.00288	CcSEcCtD
Alendronate—Abdominal pain—Ezetimibe—atherosclerosis	0.00141	0.00287	CcSEcCtD
Alendronate—Body temperature increased—Ezetimibe—atherosclerosis	0.00141	0.00287	CcSEcCtD
Alendronate—Feeling abnormal—Simvastatin—atherosclerosis	0.0014	0.00285	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0014	0.00285	CcSEcCtD
Alendronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00139	0.00283	CcSEcCtD
Alendronate—Dyspepsia—Niacin—atherosclerosis	0.00137	0.0028	CcSEcCtD
Alendronate—Dyspepsia—Pravastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alendronate—Rash—Rosuvastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alendronate—Dermatitis—Rosuvastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alendronate—Urticaria—Simvastatin—atherosclerosis	0.00135	0.00275	CcSEcCtD
Alendronate—Body temperature increased—Simvastatin—atherosclerosis	0.00134	0.00273	CcSEcCtD
Alendronate—Abdominal pain—Simvastatin—atherosclerosis	0.00134	0.00273	CcSEcCtD
Alendronate—Headache—Rosuvastatin—atherosclerosis	0.00134	0.00273	CcSEcCtD
Alendronate—Hypersensitivity—Lovastatin—atherosclerosis	0.00134	0.00272	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00133	0.00522	CbGpPWpGaD
Alendronate—Pain—Niacin—atherosclerosis	0.00133	0.00272	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—INS—atherosclerosis	0.00132	0.00516	CbGpPWpGaD
Alendronate—Pain—Pravastatin—atherosclerosis	0.00131	0.00267	CcSEcCtD
Alendronate—Constipation—Pravastatin—atherosclerosis	0.00131	0.00267	CcSEcCtD
Alendronate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00131	0.00267	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—atherosclerosis	0.00131	0.00512	CbGpPWpGaD
Alendronate—Asthenia—Lovastatin—atherosclerosis	0.0013	0.00265	CcSEcCtD
Alendronate—Pruritus—Lovastatin—atherosclerosis	0.00128	0.00262	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—SERPINE1—atherosclerosis	0.00128	0.00503	CbGpPWpGaD
Alendronate—Asthenia—Ezetimibe—atherosclerosis	0.00128	0.0026	CcSEcCtD
Alendronate—Gastrointestinal pain—Niacin—atherosclerosis	0.00127	0.0026	CcSEcCtD
Alendronate—Nausea—Rosuvastatin—atherosclerosis	0.00127	0.00259	CcSEcCtD
Alendronate—Feeling abnormal—Pravastatin—atherosclerosis	0.00126	0.00258	CcSEcCtD
Alendronate—Pruritus—Ezetimibe—atherosclerosis	0.00126	0.00257	CcSEcCtD
Alendronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00125	0.00256	CcSEcCtD
Alendronate—Hypersensitivity—Simvastatin—atherosclerosis	0.00125	0.00255	CcSEcCtD
Alendronate—Diarrhoea—Lovastatin—atherosclerosis	0.00124	0.00253	CcSEcCtD
Alendronate—Urticaria—Niacin—atherosclerosis	0.00124	0.00252	CcSEcCtD
Alendronate—Abdominal pain—Niacin—atherosclerosis	0.00123	0.00251	CcSEcCtD
Alendronate—Body temperature increased—Niacin—atherosclerosis	0.00123	0.00251	CcSEcCtD
Alendronate—Urticaria—Pravastatin—atherosclerosis	0.00122	0.00248	CcSEcCtD
Alendronate—Asthenia—Simvastatin—atherosclerosis	0.00122	0.00248	CcSEcCtD
Alendronate—Diarrhoea—Ezetimibe—atherosclerosis	0.00122	0.00248	CcSEcCtD
Alendronate—Body temperature increased—Pravastatin—atherosclerosis	0.00121	0.00247	CcSEcCtD
Alendronate—Abdominal pain—Pravastatin—atherosclerosis	0.00121	0.00247	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00121	0.00474	CbGpPWpGaD
Alendronate—Pruritus—Simvastatin—atherosclerosis	0.0012	0.00245	CcSEcCtD
Alendronate—Dizziness—Lovastatin—atherosclerosis	0.0012	0.00245	CcSEcCtD
Alendronate—Dizziness—Ezetimibe—atherosclerosis	0.00118	0.0024	CcSEcCtD
Alendronate—Diarrhoea—Simvastatin—atherosclerosis	0.00116	0.00237	CcSEcCtD
Alendronate—Vomiting—Lovastatin—atherosclerosis	0.00115	0.00235	CcSEcCtD
Alendronate—Hypersensitivity—Niacin—atherosclerosis	0.00115	0.00234	CcSEcCtD
Alendronate—Rash—Lovastatin—atherosclerosis	0.00114	0.00233	CcSEcCtD
Alendronate—Dermatitis—Lovastatin—atherosclerosis	0.00114	0.00233	CcSEcCtD
Alendronate—Headache—Lovastatin—atherosclerosis	0.00114	0.00232	CcSEcCtD
Alendronate—Vomiting—Ezetimibe—atherosclerosis	0.00113	0.00231	CcSEcCtD
Alendronate—Hypersensitivity—Pravastatin—atherosclerosis	0.00113	0.0023	CcSEcCtD
Alendronate—Dizziness—Simvastatin—atherosclerosis	0.00112	0.00229	CcSEcCtD
Alendronate—Rash—Ezetimibe—atherosclerosis	0.00112	0.00229	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00112	0.00439	CbGpPWpGaD
Alendronate—Dermatitis—Ezetimibe—atherosclerosis	0.00112	0.00228	CcSEcCtD
Alendronate—Asthenia—Niacin—atherosclerosis	0.00112	0.00228	CcSEcCtD
Alendronate—Headache—Ezetimibe—atherosclerosis	0.00111	0.00227	CcSEcCtD
Alendronate—Pruritus—Niacin—atherosclerosis	0.0011	0.00225	CcSEcCtD
Alendronate—Asthenia—Pravastatin—atherosclerosis	0.0011	0.00224	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00109	0.00426	CbGpPWpGaD
Alendronate—Pruritus—Pravastatin—atherosclerosis	0.00109	0.00221	CcSEcCtD
Alendronate—Vomiting—Simvastatin—atherosclerosis	0.00108	0.0022	CcSEcCtD
Alendronate—Nausea—Lovastatin—atherosclerosis	0.00108	0.0022	CcSEcCtD
Alendronate—Rash—Simvastatin—atherosclerosis	0.00107	0.00218	CcSEcCtD
Alendronate—Dermatitis—Simvastatin—atherosclerosis	0.00107	0.00218	CcSEcCtD
Alendronate—Diarrhoea—Niacin—atherosclerosis	0.00107	0.00217	CcSEcCtD
Alendronate—Headache—Simvastatin—atherosclerosis	0.00106	0.00217	CcSEcCtD
Alendronate—Nausea—Ezetimibe—atherosclerosis	0.00106	0.00215	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00105	0.00413	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00105	0.00413	CbGpPWpGaD
Alendronate—Diarrhoea—Pravastatin—atherosclerosis	0.00105	0.00214	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00105	0.0041	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00103	0.00405	CbGpPWpGaD
Alendronate—Dizziness—Niacin—atherosclerosis	0.00103	0.0021	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00102	0.00398	CbGpPWpGaD
Alendronate—Dizziness—Pravastatin—atherosclerosis	0.00101	0.00207	CcSEcCtD
Alendronate—Nausea—Simvastatin—atherosclerosis	0.00101	0.00205	CcSEcCtD
Alendronate—Vomiting—Niacin—atherosclerosis	0.000991	0.00202	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—atherosclerosis	0.000983	0.00385	CbGpPWpGaD
Alendronate—Rash—Niacin—atherosclerosis	0.000982	0.002	CcSEcCtD
Alendronate—Dermatitis—Niacin—atherosclerosis	0.000982	0.002	CcSEcCtD
Alendronate—Headache—Niacin—atherosclerosis	0.000976	0.00199	CcSEcCtD
Alendronate—Vomiting—Pravastatin—atherosclerosis	0.000975	0.00199	CcSEcCtD
Alendronate—Rash—Pravastatin—atherosclerosis	0.000967	0.00197	CcSEcCtD
Alendronate—Dermatitis—Pravastatin—atherosclerosis	0.000966	0.00197	CcSEcCtD
Alendronate—Headache—Pravastatin—atherosclerosis	0.000961	0.00196	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000939	0.00368	CbGpPWpGaD
Alendronate—Nausea—Niacin—atherosclerosis	0.000926	0.00189	CcSEcCtD
Alendronate—Nausea—Pravastatin—atherosclerosis	0.000911	0.00186	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000891	0.00349	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000891	0.00349	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000891	0.00349	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000891	0.00349	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00088	0.00345	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00085	0.00333	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000815	0.00319	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—atherosclerosis	0.00081	0.00317	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MAPK3—atherosclerosis	0.000787	0.00308	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000784	0.00307	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LDLRAP1—atherosclerosis	0.000775	0.00304	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000775	0.00303	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000757	0.00297	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLTP—atherosclerosis	0.000728	0.00285	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOA4—atherosclerosis	0.000688	0.0027	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000683	0.00267	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000675	0.00264	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000671	0.00263	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000667	0.00261	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000651	0.00255	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—AKT1—atherosclerosis	0.000643	0.00252	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LTA4H—atherosclerosis	0.000632	0.00247	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG8—atherosclerosis	0.000632	0.00247	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000624	0.00244	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRH1—atherosclerosis	0.000614	0.00241	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOA2—atherosclerosis	0.000592	0.00232	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000589	0.00231	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00058	0.00227	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—atherosclerosis	0.000575	0.00225	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BGN—atherosclerosis	0.000547	0.00214	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000536	0.0021	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000525	0.00206	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000513	0.00201	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG1—atherosclerosis	0.000499	0.00196	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA4—atherosclerosis	0.000482	0.00189	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CST3—atherosclerosis	0.000477	0.00187	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FABP4—atherosclerosis	0.000469	0.00184	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LCAT—atherosclerosis	0.000469	0.00184	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA4—atherosclerosis	0.000461	0.00181	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP7A1—atherosclerosis	0.000453	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NAMPT—atherosclerosis	0.000452	0.00177	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOC3—atherosclerosis	0.000446	0.00175	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL4—atherosclerosis	0.000444	0.00174	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LDLR—atherosclerosis	0.000443	0.00174	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000433	0.0017	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000431	0.00169	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HSPA1B—atherosclerosis	0.000428	0.00168	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP27A1—atherosclerosis	0.000418	0.00164	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA2—atherosclerosis	0.000415	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NCF1—atherosclerosis	0.000415	0.00163	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000412	0.00161	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000406	0.00159	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000402	0.00157	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLA2G2A—atherosclerosis	0.000397	0.00155	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA2—atherosclerosis	0.000397	0.00155	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALOX15—atherosclerosis	0.000397	0.00155	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALOX5AP—atherosclerosis	0.000397	0.00155	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—UTS2—atherosclerosis	0.000396	0.00155	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCG5—atherosclerosis	0.000392	0.00154	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000391	0.00153	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CYBA—atherosclerosis	0.00039	0.00153	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PARP1—atherosclerosis	0.000382	0.0015	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000379	0.00149	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASR—atherosclerosis	0.000379	0.00149	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPA—atherosclerosis	0.000378	0.00148	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000372	0.00146	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BGN—atherosclerosis	0.000366	0.00144	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000364	0.00143	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA5—atherosclerosis	0.000363	0.00142	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CNR2—atherosclerosis	0.000353	0.00138	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000352	0.00138	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLA2G1B—atherosclerosis	0.000349	0.00137	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000345	0.00135	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000342	0.00134	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000341	0.00134	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALOX5—atherosclerosis	0.000337	0.00132	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000322	0.00126	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VWF—atherosclerosis	0.000314	0.00123	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOC3—atherosclerosis	0.000312	0.00122	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000312	0.00122	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LDLR—atherosclerosis	0.000311	0.00122	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL3—atherosclerosis	0.000303	0.00119	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NAMPT—atherosclerosis	0.000302	0.00119	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000301	0.00118	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LIPC—atherosclerosis	0.000301	0.00118	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOC3—atherosclerosis	0.000299	0.00117	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LDLR—atherosclerosis	0.000297	0.00116	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NCF1—atherosclerosis	0.00029	0.00114	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CETP—atherosclerosis	0.00029	0.00114	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOB—atherosclerosis	0.000287	0.00112	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SCARB1—atherosclerosis	0.000278	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCR2—atherosclerosis	0.000274	0.00107	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDNRA—atherosclerosis	0.000274	0.00107	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LPL—atherosclerosis	0.000274	0.00107	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CYBA—atherosclerosis	0.000273	0.00107	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.00027	0.00106	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PARP1—atherosclerosis	0.000267	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GHRL—atherosclerosis	0.000267	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLAT—atherosclerosis	0.000267	0.00105	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKCG—atherosclerosis	0.000266	0.00104	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMGCR—atherosclerosis	0.000262	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—atherosclerosis	0.000247	0.000967	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFB—atherosclerosis	0.00024	0.000941	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000237	0.000927	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KNG1—atherosclerosis	0.000235	0.000919	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ABCA1—atherosclerosis	0.000234	0.000916	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR1—atherosclerosis	0.000233	0.000914	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—atherosclerosis	0.00023	0.0009	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CAV1—atherosclerosis	0.000228	0.000892	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLG—atherosclerosis	0.000227	0.000891	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOA1—atherosclerosis	0.000227	0.00089	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SOCS3—atherosclerosis	0.000215	0.000843	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—atherosclerosis	0.000214	0.000839	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP3—atherosclerosis	0.000208	0.000815	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF2—atherosclerosis	0.000207	0.000811	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOB—atherosclerosis	0.000201	0.000787	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—atherosclerosis	0.000201	0.000786	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDN1—atherosclerosis	0.000198	0.000775	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL5—atherosclerosis	0.000196	0.000769	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—atherosclerosis	0.000196	0.000769	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOB—atherosclerosis	0.000192	0.000753	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LPL—atherosclerosis	0.000192	0.000752	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—atherosclerosis	0.000187	0.000732	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCG—atherosclerosis	0.000187	0.000731	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPL—atherosclerosis	0.000183	0.000719	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SPP1—atherosclerosis	0.000182	0.000712	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—atherosclerosis	0.00018	0.000706	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GPX1—atherosclerosis	0.000179	0.000701	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CD36—atherosclerosis	0.000174	0.000683	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—atherosclerosis	0.000172	0.000674	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFB—atherosclerosis	0.000168	0.000659	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—atherosclerosis	0.000165	0.000647	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGT—atherosclerosis	0.000164	0.000643	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARA—atherosclerosis	0.000162	0.000635	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—atherosclerosis	0.000161	0.00063	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—atherosclerosis	0.000161	0.00063	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CAV1—atherosclerosis	0.000159	0.000624	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA1—atherosclerosis	0.000159	0.000623	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—atherosclerosis	0.000157	0.000617	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AGT—atherosclerosis	0.000157	0.000615	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—atherosclerosis	0.000154	0.000602	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—atherosclerosis	0.000154	0.000602	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAV1—atherosclerosis	0.000152	0.000597	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA1—atherosclerosis	0.000152	0.000596	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—F2—atherosclerosis	0.000152	0.000594	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000145	0.000569	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CG—atherosclerosis	0.000139	0.000544	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—atherosclerosis	0.000137	0.000538	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCL2—atherosclerosis	0.000135	0.00053	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—atherosclerosis	0.000134	0.000525	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—atherosclerosis	0.000133	0.000521	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—atherosclerosis	0.000131	0.000515	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000126	0.000494	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—atherosclerosis	0.000123	0.000481	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—atherosclerosis	0.00012	0.000472	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—atherosclerosis	0.00012	0.000472	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK3—atherosclerosis	0.000117	0.000459	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—atherosclerosis	0.000115	0.000451	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—atherosclerosis	0.000114	0.000446	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—atherosclerosis	0.000107	0.000419	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—atherosclerosis	0.000105	0.000413	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—atherosclerosis	9.67e-05	0.000379	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKB1—atherosclerosis	9.56e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—atherosclerosis	9.4e-05	0.000368	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—atherosclerosis	8.68e-05	0.00034	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—atherosclerosis	8.59e-05	0.000337	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—atherosclerosis	8.57e-05	0.000336	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK3—atherosclerosis	8.21e-05	0.000322	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—atherosclerosis	7.97e-05	0.000312	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—atherosclerosis	7.91e-05	0.00031	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—atherosclerosis	6e-05	0.000235	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—atherosclerosis	5.54e-05	0.000217	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—atherosclerosis	5.3e-05	0.000207	CbGpPWpGaD
